Startseite › Lungenkrebs › Florida › Tampa
Klinische Studien zu Lungenkrebs in Tampa, FL
29 Studien zu Lungenkrebs suchen Teilnehmer an Standorten in und um Tampa (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center, Tampa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Moffitt Cancer Center, Tampa
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center-International Plaza, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- und 1 weitere
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Teilnehmer gesuchtPhase 3
- H Lee Moffitt Cancer Center and Research Institute, Tampa
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Florida Cancer Specialists, Tampa
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Teilnehmer gesuchtPhase 2/3
- Local Institution - 0523, Tampa
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Teilnehmer gesuchtPhase 2/3
- H. Lee Moffit Cancer center and research institute, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
Teilnehmer gesuchtPhase 1
- Moffitt Cancer Center, Tampa
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, Tampa
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Teilnehmer gesucht
- James A. Haley Veterans' Hospital, Tampa
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Teilnehmer gesuchtPhase 1/2
- H Lee Moffitt Cancer Center and Research Institute, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Teilnehmer gesuchtPhase 1
- Moffitt Cancer Center, Tampa
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Teilnehmer gesuchtPhase 2
- H Lee Moffitt Cancer Center and Research Institute, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Teilnehmer gesuchtPhase 1
- Lee Moffitt Cancer Center, Tampa
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2/3
- Moffitt Cancer Center, Tampa
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Lungenkrebs-Studien in anderen Städten
- Houston, TX78 Studien
- Boston, MA62 Studien
- New York City, NY60 Studien
- Los Angeles, CA45 Studien
- Washington, DC41 Studien
- Arlington, VA41 Studien
- Chicago, IL41 Studien
- Nashville, TN40 Studien
- Baltimore, MD40 Studien
- St. Louis, MO39 Studien
- Columbus, OH37 Studien
- Philadelphia, PA36 Studien
Weitere Studien in Tampa
- Nichtkleinzelliges Lungenkarzinom51 Studien
- Brustkrebs43 Studien
- Krebs (alle Arten)39 Studien
- Kolorektales Karzinom33 Studien
- Metastasierender Krebs29 Studien
- Akute myeloische Leukämie29 Studien
- Bauchspeicheldrüsenkrebs26 Studien
- Eierstockkrebs21 Studien
- Myelodysplastische Syndrome19 Studien
- Melanom19 Studien
- Herzinsuffizienz18 Studien
- Prostatakrebs18 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.